HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerard B Nash Selected Research

Necrosis

2/2011Delay of migrating leukocytes by the basement membrane deposited by endothelial cells in long-term culture.
1/2010Responses of endothelial cells from different vessels to inflammatory cytokines and shear stress: evidence for the pliability of endothelial phenotype.
8/2009Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment.
6/2007Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype.
1/2006An in vitro model for analysing neutrophil migration into and away from the sub-endothelial space: Roles of flow and CD31.
10/2005Prolonged culture of endothelial cells and deposition of basement membrane modify the recruitment of neutrophils.
8/2005Differing mechanisms of leukocyte recruitment and sensitivity to conditioning by shear stress for endothelial cells treated with tumour necrosis factor-alpha or interleukin-1beta.
3/2005Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes.
5/2004Methods for exposing multiple cultures of endothelial cells to different fluid shear stresses and to cytokines, for subsequent analysis of inflammatory function.
9/2003Monocytes initiate a cycle of leukocyte recruitment when cocultured with endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerard B Nash Research Topics

Disease

11Inflammation (Inflammations)
01/2018 - 10/2003
10Necrosis
02/2011 - 09/2003
6Neoplasms (Cancer)
01/2016 - 07/2003
5Atherosclerosis
01/2020 - 01/2006
3Reperfusion Injury
06/2011 - 01/2006
2Thrombosis (Thrombus)
01/2020 - 01/2015
2Abdominal Aortic Aneurysm
01/2018 - 08/2011
2Vascular Diseases (Vascular Disease)
01/2018 - 11/2010
2Wounds and Injuries (Trauma)
01/2017 - 06/2012
2Malaria
01/2014 - 07/2007
2Infections
10/2013 - 11/2010
2Rheumatoid Arthritis
01/2009 - 07/2008
2Vasculitis (Vasculitides)
05/2008 - 01/2005
2Peripheral Arterial Disease
12/2007 - 06/2007
2Hypoxia (Hypoxemia)
02/2006 - 01/2006
1Peritonitis
01/2022
1Aneurysm (Aneurysms)
01/2018
1Arthritis (Polyarthritis)
12/2017
1Synovitis
12/2017
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2014
1Virus Diseases (Viral Diseases)
10/2013
1Disease Progression
04/2013
1Atherosclerotic Plaque (Atheroma)
04/2013
1Chronic Disease (Chronic Diseases)
03/2012
1Carcinogenesis
11/2010
1Kaposi Sarcoma (Kaposi's Sarcoma)
11/2010
1Pulmonary Arterial Hypertension
11/2010
1Primary Effusion Lymphoma
11/2010
1Neoplasm Metastasis (Metastasis)
09/2009
1Osteoarthritis
01/2009
1Pain (Aches)
06/2007
1Hyperplasia
01/2006
1Cardiac Sudden Death (Sudden Cardiac Arrest)
07/2005
1Coronary Disease (Coronary Heart Disease)
07/2005
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2005
1Arteritis
09/2003
1Cicatrix (Scar)
02/2003

Drug/Important Bio-Agent (IBA)

13CytokinesIBA
12/2017 - 05/2004
5Proteins (Proteins, Gene)FDA Link
05/2015 - 11/2010
5ChemokinesIBA
08/2011 - 09/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 09/2003
3adhesion receptorIBA
01/2016 - 09/2003
2Small Interfering RNA (siRNA)IBA
01/2022 - 06/2012
2Apolipoproteins E (ApoE)IBA
01/2020 - 01/2018
2InterleukinsIBA
01/2018 - 06/2007
2AntibodiesIBA
01/2018 - 05/2008
2Interleukin-6 (Interleukin 6)IBA
12/2017 - 03/2012
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2010 - 08/2005
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
08/2009 - 06/2007
2Fish OilsIBA
12/2007 - 06/2007
2Actins (F Actin)IBA
01/2005 - 02/2003
1ZymosanIBA
01/2022
1Polystyrenes (Polystyrene)IBA
01/2020
1SuspensionsIBA
01/2020
1ImmunosorbentsIBA
01/2018
1src-Family KinasesIBA
01/2018
1EnzymesIBA
01/2018
1Protein Isoforms (Isoforms)IBA
01/2018
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2017
1CoagulantsIBA
01/2017
1Metalloproteases (Metalloproteinases)IBA
01/2016
1CD13 Antigens (Alanine Aminopeptidase)IBA
01/2016
1AdiponectinIBA
05/2015
1Peptides (Polypeptides)IBA
05/2015
1latency-associated nuclear antigenIBA
10/2013
1Platelet Endothelial Cell Adhesion Molecule-1IBA
04/2013
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2012
1Prostaglandins DIBA
08/2011
1Junctional Adhesion Molecule CIBA
06/2011
1CollagenIBA
02/2011
1InterferonsIBA
02/2011
1GelsIBA
02/2011
1Lysine (L-Lysine)FDA Link
11/2010
1Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
11/2010
1Cell Surface ReceptorsIBA
11/2010
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2010
1UbiquitinIBA
11/2010
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
11/2010
1GlycosaminoglycansIBA
11/2009
1E-SelectinIBA
09/2009
1LigandsIBA
09/2009
1Galectin 3 (LGALS3)IBA
09/2009
1Antigen Receptors (Antigen Receptor)IBA
07/2008
1Starch (Cornstarch)IBA
05/2008
1Peroxidase (Myeloperoxidase)IBA
05/2008
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2007
1Interleukin-10 (Interleukin 10)IBA
06/2007
1LipidsIBA
01/2006
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2005
1MetyraponeFDA Link
07/2005
1Immunoglobulin G (IgG)IBA
01/2005
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2005

Therapy/Procedure

2Therapeutics
01/2014 - 07/2003
1Replacement Arthroplasty
12/2017
1Endovascular Aneurysm Repair
08/2011